Novel thiosemicarbazide derivatives with 4-nitrophenyl group as multi-target drugs: α-glucosidase inhibitors with antibacterial and antiproliferative activity.

doi:10.1016/j.biopha.2017.07.049

Paper

Novel thiosemicarbazide derivatives with 4-nitrophenyl group as multi-target drugs: α-glucosidase inhibitors with antibacterial and antiproliferative activity.

Published Sep 1, 2017 · Maciej Wos, M. Miazga-Karska, A. Kaczor

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Q1 SJR score

30

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Rigorous Journal

Study Snapshot

Novel thiosemicarbazide derivatives with 4-nitrophenyl group show potential as multi-target drugs with antibacterial, antiproliferative, and -glucosidase inhibitory activities.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Novel thiosemicarbazide derivatives with 4-nitrophenyl group as multi-target drugs: α-glucosidase inhibitors with antibacterial and antiproliferative activity.

References

Citations